Navigation Links
Damon Runyon Cancer Research Foundation grants prestigious awards to 20 top young scientists
Date:1/13/2014

on how oncogenes affect cellular metabolism in pancreatic cancer. In particular, he is interested in understanding how mutations in the oncogene Kras alter cellular metabolism in pancreatic ductal adenocarcinoma to facilitate cell growth. He will determine if distinct components of Kras-mediated signaling can be targeted for therapeutic gain. Ultimately, this work aims to translate our understanding of pancreatic cancer cell metabolism into therapies for this devastating disease.

Raymond E. Moellering, PhD (Damon Runyon Fellow '11-'13), The Scripps Research Institute, La Jolla, California

Dr. Moellering is interested in understanding the link between alteration of metabolic pathways and corresponding protein modifications that occur in cancer cells. In addition, he is investigating whether cancer cells use small molecule signaling, known as quorum-sensing, to communicate and thus control tumor initiation, growth and metastasis. His goal is to provide insights into many aspects of tumor progression and to potentially identify new opportunities for therapeutic intervention.

Nathan D. Thomsen, PhD (Damon Runyon Fellow '11-'13), University of California, San Francisco, California

Dr. Thomsen is studying the molecular interactions that are required for specific signaling pathways in the cell. In cancer cells, these signaling pathways are often disrupted or misregulated. Using sophisticated new techniques he has developed, he will "capture and trap" proteins in real time, as they are signalingsimilar to a video freeze-frame. He plans to then engineer antibodies that will specifically target and inhibit these pathways, which can be used to learn more about the molecular mechanisms underlying signaling and may eventually be developed into therapeutics for cancer and other diseases.

Cole Trapnell, PhD (Damon Runyon Fellow '11-'14), Harvard University, Cambridge, Massachusetts '/>"/>

Contact: Yung S. Lie, Ph.D.
yung.lie@damonrunyon.org
212-455-0521
Damon Runyon Cancer Research Foundation
Source:Eurekalert

Page: 1 2 3 4 5 6 7

Related biology news :

1. Damon Runyon Cancer Research Foundation awards $3.6 M to 9 top young clinical investigators
2. Damon Runyon Cancer Research Foundation grants prestigious awards to 17 young scientists
3. Damon Runyon-Rachleff Innovation Awards granted for pioneering ideas in cancer research
4. Mechanism affecting risk of prostate cancer is found
5. LSUHSC research reveals structure of master regulator and new drug target for autism, cervical cancer
6. Cancer drug protects against diabetes
7. Researchers discover a tumor suppressor gene in a very aggressive lung cancer
8. Novel noninvasive therapy prevents breast cancer formation in mice
9. UTSW study identifies potential therapeutic target for incurable, rare type of soft-tissue cancer
10. International team completes systematic, genomic study of cervical cancer
11. Breast cancer patients experience fewer side effects from anticancer drug when receiving acupuncture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2014)... crop residue to make ethanol and other biofuels reduces ... gasoline, according to a study published today in the ... by a University of Nebraska-Lincoln team of researchers cast ... meet federal mandates to ramp up ethanol production and ... stalks, leaves and cobs in cornfields after harvest -- ...
(Date:4/18/2014)... adds a twist to the story of how barnyard chickens ... 21 in the journal Proceedings of the National Academy ... chickens that lived 200-2300 years ago in Europe, researchers report ... have looked far different from the chickens we know today. ... associate with modern domestic chickens -- such as their yellowish ...
(Date:4/17/2014)... trials to treat tuberculosis could be the basis for ... bacteria, fungal infections and parasites, yet evade resistance, according ... collaborators. , Led by U. of I. chemistry professor ... drug SQ109 attacks the tuberculosis bacterium, how the drug ... to malaria and how targeting multiple pathways reduces ...
Breaking Biology News(10 mins):Study casts doubt on climate benefit of biofuels from corn residue 2Study casts doubt on climate benefit of biofuels from corn residue 3Ancient DNA offers clues to how barnyard chickens came to be 2Multitarget TB drug could treat other diseases, evade resistance 2
... origins of holiday giving and finds that our early ... arguably the foundational basis of cooperation in humans," writes ... feature of reciprocity is the contingent relationship between acts ... important because it sets the rules for who qualifies ...
... the United States could be grown inexpensively and safely ... of Central Florida molecular biologist has found. , Mice ... Daniell's laboratory through the genetic engineering of tobacco plants ... Institutes of Health researchers. The results of the NIH-funded ...
... -- a critical protein that mediates the body's defense against ... soon have greater therapeutic value as the result of a ... in St. Louis. , "Essentially, we found a way ... Michael J. Holtzman, M.D., the Selma and Herman Seldin Professor ...
Cached Biology News:Effective, safe anthrax vaccine can be grown in tobacco plants 2Effective, safe anthrax vaccine can be grown in tobacco plants 3Greasing interferon's gears may pave way to greater therapeutic benefits, fewer side effects 2
(Date:1/14/2014)... Toronto, Canada (PRWEB) January 14, 2014 ... and its motives and methods in product development and ... of the industry. This mistrust, fueled by concerns about ... further fed by reports of spectacular fines to the ...
(Date:1/14/2014)... Ontario , Jan. 14, 2014   Kinaxis ®, provider ... SCM ) and sales and operations planning ( S&OP ) ... Biomanufacturing Summit , which will be held at the ... the conference, join Kinaxis customer Elisabeth Kaszas , Director ...
(Date:1/14/2014)... 14, 2014 During the 1600’s through the ... “The Doctor’s Plague.” In this time period, doctors did not ... at times, to the death of vulnerable patients. In the ... that they may be unwittingly transmitting herpes viruses to their ...
(Date:1/14/2014)... Holloway America today announced an addition ... reports (MTRs) for all pressure vessels and tank parts ... particularly important for equipment that must meet ASME, CE, ... search functionality that allows authorized users to quickly locate ...
Breaking Biology Technology:The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness" 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 3Pressure Vessel Design and Fabrication Company Builds Database for Material Test Reports 2Pressure Vessel Design and Fabrication Company Builds Database for Material Test Reports 3
... Cephalon, Inc. (NASDAQ: CEPH ) today ... Statement with the Securities and Exchange Commission (SEC) urging ... remove Cephalon,s entire Board of Directors and replace them ... of the Statement to shareholders of record together with ...
... NEW YORK, April 21, 2011 Collins Stewart LLC ... healthcare investment banking alliance with Beal Advisors and Liberty ... target, originate and execute public and private equity transactions ... Tree Advisors are US-based boutique healthcare advisory firms. Georgia ...
... 21, 2011 The Stanford University School of ... of a Phase 1/2a clinical trial testing the ... therapy product, SB623, on patients suffering from stable ... regarding this clinical trial, please refer to the ...
Cached Biology Technology:Cephalon Files Definitive Consent Revocation Statement, Commences Mailing to Shareholders 2Cephalon Files Definitive Consent Revocation Statement, Commences Mailing to Shareholders 3Cephalon Files Definitive Consent Revocation Statement, Commences Mailing to Shareholders 4Cephalon Files Definitive Consent Revocation Statement, Commences Mailing to Shareholders 5Cephalon Files Definitive Consent Revocation Statement, Commences Mailing to Shareholders 6Cephalon Files Definitive Consent Revocation Statement, Commences Mailing to Shareholders 7Cephalon Files Definitive Consent Revocation Statement, Commences Mailing to Shareholders 8Cephalon Files Definitive Consent Revocation Statement, Commences Mailing to Shareholders 9Cephalon Files Definitive Consent Revocation Statement, Commences Mailing to Shareholders 10Collins Stewart Announces Formation of Healthcare Investment Banking Alliance 2Collins Stewart Announces Formation of Healthcare Investment Banking Alliance 3Stanford and SanBio Announce a Clinical Trial of Cell Therapy for Stroke Disability 2
CQCS kit for first KR 4i , (first unit)....
... 384, compatible with hood ... handling system for 384-well ... accurately prepares large quantities ... The Wellpro also performs ...
...
...
Biology Products: